I’m a clinical pharmacist and molecular pharmacologist working as research group leader at Saarland University’s Preclinical Center for Molecular Signal Processing (PZMS) in the Pharmacology & Toxicology department of the medical faculty. My research focuses on extracellular vesicles (EVs) and proteases (especially ADAM10 and ADAM17) as drivers and biomarkers of inflammation, infection, and cancer. I’m particularly interested in how EV-associated protease activity reshapes immune responses and barrier function during acute lung infections (e.g., Pseudomonas aeruginosa, COVID-19) and in tumor microenvironments (e.g., HNSCC).
I’m a clinical pharmacist and molecular pharmacologist working as research group leader at Saarland University’s Preclinical Center for Molecular Signal Processing (PZMS) in the Pharmacology & Toxicology department of the medical faculty. My research focuses on extracellular vesicles (EVs) and proteases (especially ADAM10 and ADAM17) as drivers and biomarkers of inflammation, infection, and cancer. I’m particularly interested in how EV-associated protease activity reshapes immune responses and barrier function during acute lung infections (e.g., Pseudomonas aeruginosa, COVID-19) and in tumor microenvironments (e.g., HNSCC).